Newsroom

Displaying 41–50 of 124

August 14, 2024

Seer Appoints Nicolas Roelofs to its Board of Directors

August 9, 2024

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

August 8, 2024

Seer Reports Second Quarter 2024 Financial Results

July 18, 2024

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

June 11, 2024

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

June 2, 2024

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study

May 8, 2024

Seer Reports First Quarter 2024 Financial Results

May 8, 2024

Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions

April 23, 2024

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

February 29, 2024

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence